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To maintain a quiescent gut microenvironment, proper regulation of immune responses initiated by
pro-inﬂammatory immune subsets is required. Several types of regulatory T cells are reported to
exert pivotal roles in achieving this. Among various types of regulatory T cells, the crucial role of
Foxp3+ Treg cells has been well documented. Furthermore, accumulating evidence demonstrates
that both microbial and dietary factors inﬂuence the induction and suppressor functions of intesti-
nal Foxp3+ Treg cells. Foxp3+ Treg cells are a highly activated T cell subset which responds rapidly to
environmental and nutritional stimuli. Thus, sufﬁcient nutrient supply is required to fuel the high
energetic status of Foxp3+ Treg cells for the regulation of intestinal immunity.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The gut is a unique organ in that immune cells related to both
adaptive and innate immunity are continuously exposed to numer-
ous numbers of foreign antigens. For example, the intestinal lumen
contains 1011 bacteria per gram of contents [1], and also various
types of diet-derived products. While pro-inﬂammatory immune
responses confer protection against invasive pathogens, dysregula-
tion of the immune response results in intestinal inﬂammation, or
inﬂammatory bowel disease (IBD). Notably, in patients with IBD,
enhanced Th1- and Th17-mediated immunity is demonstrated in
the lamina propria.
Several types of innate immune cells are reported to be respon-
sible for inducing Th1- and Th17-mediated immunity in the intes-
tines. For example, CD103+CD11b+ dendritic cells efﬁciently
produce IL-6 [2], whereas a subset of CX3CR1+ dendritic cells that
recognize microbial-derived ATP produces IL-6 and IL-23p19 [3].
Th1 and Th17 cells induced by these innate immune subsets pro-
duce various pro-inﬂammatory cytokines, including IFN-c, or IL-
17 and GM-CSF respectively [4].To achieve a quiescent gut microenvironment, several types of
immune cells play essential roles in curbing inappropriate immune
responses. Foxp3+ regulatory T cells (Foxp3+ Treg cells) and IL-10
producing T cells (Tr1 cells) have attracted particular interest over
the past decade for their critical roles in suppressing intestinal
inﬂammation [5].
In this review, we will discuss recent advances in our under-
standing of the mechanism of regulation of intestinal inﬂammation
by regulatory T cells, especially Foxp3+ Treg cells, and describe how
these regulatory T cells are maintained by microbial and dietary
factors.
2. Intestinal regulatory T cells
The signiﬁcant role of Foxp3+ Treg cells in suppressing pro-
inﬂammatory immune responses in various autoimmune diseases
is well documented. For example, patients who possess a mutation
in the FOXP3 gene are known to develop a multiple organ inﬂam-
mation, called IPEX (immune dysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome) [6]. Moreover, mice deﬁcient
for the FOXP3 gene, called Scufy mice [7], develop spontaneous
inﬂammation in various organs [8], and transfer of Foxp3+ Treg
cells is capable of suppressing disease in these mice [9]. As further
evidence that Foxp3+ Treg cells are capable of suppressing intesti-
nal inﬂammation, adoptive transfer of Foxp3 deﬁcient naïve T cells
induce colitis [10]. Taken together, these observations highlight the
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inﬂammation.
Anti-inﬂammatory cytokine production is an indispensable
mode of regulation mediated by Foxp3+ Treg cells against intestinal
inﬂammation. The importance of IL-10 production by Foxp3+ Treg
cells is particularly well recognized. Intestinal Foxp3+ Treg cells are
unique in that as many as 50% of Foxp3+ Treg cells express IL-10 in
the steady state, compared with those in other organs [11]. More-
over, speciﬁc deletion of IL-10 in Foxp3+ Treg cells is reported to
cause spontaneous colitis [12].
Recently, mice deﬁcient for the IL-10 receptor on Foxp3+ Treg
cells were also shown to develop intestinal inﬂammation [13]. In
these mice, the Th17 cell-mediated immune response is aug-
mented, indicating that IL-10 might also potentiate the suppressive
capacity of Foxp3+ Treg cells in an autocrine manner [13].
In addition to these observations obtained from murine studies,
the critical role of IL-10 in regulating intestinal inﬂammation is
also suggested by studies of IBD patients [14]. The IL-10 gene
was recently shown to be a susceptibility gene by genome-wide
association studies, and mutations in IL-10, IL-10RA or IL-10RB
genes lead to the development of early onset IBD [15].
In addition to the suppressive effect of IL-10, several reports
demonstrate the regulatory functions of TGF-b expressed by Treg
cells. Neutralization of TGF-b by monoclonal antibodies abolishes
the protective capacity of CD4+ CD25+ Treg cells against experi-
mental colitis [16]. Moreover, a fraction of CD4+ CD25+ Treg cells
are reported to express membrane-bound TGF-b [17]. The require-
ment for TGF-b on CD4+ CD25+ Treg cells was further elucidated in
a study that demonstrated that CD4+ CD25+ Treg cells deﬁcient for
TGF-b fail to inhibit colitis induced by transferring naïve CD4+ T
cells into Rag2-deﬁcient mice [18].
More recently, a novel anti-inﬂammatory cytokine, IL-35, was
identiﬁed as a critical factor for Foxp3+ Treg cell function. IL-35
comprises Epstein-Barr virus induced 3 (EBI3) and IL-12a, and is
expressed in Foxp3+ Treg cells after contact with effector T cells
[19]. A previous report also shows that IL-35 is preferentially se-
creted by Foxp3+ Treg cells [20]. Although the precise role of IL-
35 in intestinal inﬂammation remains elusive, Foxp3+ Treg cells
deﬁcient for IL-35 fail to ameliorate colitis induced by transferring
CD4+ CD25 CD45RBhigh T cells into Rag1-deﬁcient mice [20].
3. Origin of Foxp3+ Treg cells in the intestine
Foxp3+ Treg cells generated in the thymus, or naturally occur-
ring Treg cells (nTreg) cells, are generally considered to recognize
self-antigens, thereby playing a major role in suppressing systemic
autoimmunity. On the other hand, it is well acknowledged that
Foxp3+ Treg cells can be induced extrathymically [21]. The gener-
ation of these Foxp3+ Treg cells in the periphery, or iTreg cells, de-
pends on foreign antigens. The critical roles played by TGF-b and
retinoic acid (RA) in the induction of iTreg cells are also well
known [5].
In contrast to the differentiation of Th17 cells after combined
stimulation with IL-6 and TGF-b, TGF-b alone will efﬁciently induce
iTreg cells from naïve CD4+ T cells [5]. Moreover, as discussed be-
low, RA produced by intestinal dendritic cells which express retinal
dehydrogenase (RALDH) effectively promotes the induction of
iTreg cells [5]. Thus, taking into account that both TGF-b and RA
are abundantly expressed in the intestine and the gut-associated
lymphoid tissues (GALT), the intestinal immune system is an ideal
site for iTreg cell generation.
With regard to their differentiating processes, proximal pro-
moter and intronic regulatory elements, or conserved non-coding
sequences (CNSs), are recently recognized to be crucial for the sta-
ble expression of the Foxp3 gene. Moreover, nTreg cells and iTregcells have been shown to possess distinct mechanisms controlling
differentiation [21].
For the generation of nTreg cells, both the intensity and dura-
tion of T cell receptor (TCR) stimulation and CD28 co-stimulation
are considered to be essential. The signals received from the TCR
and CD28 lead to the activation of the transcriptional factors NF-
jB and cAMP response element-binding protein (CREB) [21]. The
c-Rel subunit of NF-jB binds to the CNS3 element and induces
chromatin remodeling at the Foxp3 locus. On the other hand, it is
also indicated that the binding of CREB to the CNS2 element may
stabilize Foxp3 expression through demethylation [21].
By contrast, for the induction of iTreg cells, the essential role of
the CNS1 element has been reported. TGF-b signaling initiates the
recruitment of Smad3 to the CNS1 element. The activated retinoic
acid receptor is also reportedly recruited to the CNS1 element [21].
Importantly, in CNS1-deﬁcient mice, the frequency of Foxp3+ Treg
cells is signiﬁcantly reduced in both the small intestine and the co-
lon, resulting in Th2-type intestinal inﬂammation [22]. Thus, the
critical role of iTreg cells in regulating intestinal inﬂammation is
proven.
To directly discriminate between nTreg cells and iTreg cells
in vivo, several surrogate makers have been suggested. Previous re-
ports indicate that Helios, a member of the Ikaros transcription fac-
tor family, is speciﬁcally expressed by nTreg cells [23]. Notably,
about half of the Foxp3+ Treg cells in the colon are negative for He-
lios in speciﬁc pathogen-free (SPF) mice, suggesting that nTreg and
iTreg cells contribute equally to the pool of Foxp3+ Treg cells pres-
ent in the intestine [11]. Considering that the number of Helios-
negative Foxp3+ Treg cells is remarkably reduced in germ-free
(GF) mice, exposure to commensal microbiota plays a critical role
for the induction of iTreg cells. However, recently several reports
indicate that Helios might be a less reliable marker for discriminat-
ing nTreg cells than previously suggested [24]. In addition to He-
lios, neuropilin-1 (Nrp1), a novel receptor for semaphorin and
vascular endothelial growth factor (VEGF), was recently identiﬁed
as an additional surrogate marker for nTreg cells. In line with the
observations on Helios expression, about half of Foxp3+ Treg cells
in the intestine are positive for Nrp1 [25].
High-throughput sequencing of the TCRs of Foxp3+ Treg cells
has provided substantial insight into how nTreg and iTreg cells
are actively involved in regulating intestinal inﬂammation against
commensal microbiota [26,27].
In one report, it was demonstrated that most of the TCRs of co-
lonic Foxp3+ Treg cells have a distinct TCR repertoire from those in
other organs [26]. The TCRs of colonic Foxp3+ Treg cells were elu-
cidated to be speciﬁc for bacterial antigens [26]. Moreover, the
transfer of effector T cells harboring the same TCRs as colonic
Foxp3+ Treg cells induced severe colitis. Notably, these TCRs iso-
lated from colonic Foxp3+ Treg cells poorly facilitated the develop-
ment of nTreg cells [26]. Thus, iTreg cells generated after exposure
to commensal microbiota largely contribute to protection against
the spontaneous development of intestinal inﬂammation.
However, it remains to be revealed to what extent each Foxp3+
Treg subset contributes to the pool of Foxp3+ Treg population in
the intestine. More recently, another report demonstrated conﬂict-
ing results, where approximately half of the dominant TCRs ex-
pressed on intestinal Foxp3+ Treg cells were demonstrated to be
present on CD4+ Foxp3+ thymocytes [27].
4. Microbiota responsible for inducting intestinal regulatory T
cells
There is accumulating evidence that commensal microbiota
play a crucial role in the development of intestinal immunity. In
GF mice, the development of Peyer’s patches is impaired and the
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frequencies of Th17 and Foxp3+ Treg cells are reportedly reduced
in the lamina propria of GF mice [3,11]. Comparison of the intesti-
nal microbiota of mice derived from different vendors revealed
that segmented ﬁlamentous bacteria (SFB) are a potent inducer
of Th17 cells in the small intestine [28]. Although the precise
mechanism as to how SFB efﬁciently induce Th17 cells is not yet
clear, TGF-b and IL-6 are suggested to play a possible role in their
induction [29].
Regarding the reduced induction of Foxp3+ Treg cells in GF
mice, the reduction is observed exclusively in the colon, but not
in the small intestine, indicating that certain types of microbiota
may be responsible for the induction of Foxp3+ Treg cells in this
location [11]. Recently, spore-forming components of intestinal
microbiota, particularly those belonging to the genus Clostridium
clusters IV and XIVa, were identiﬁed as potent inducers of Foxp3+
Treg cells in the colon. The colonization of GF mice with a mixture
of 46 strains of Clostridium efﬁciently induced the generation of
Foxp3+ Treg cells in the colon [11]. The majority of Foxp3+ Treg
cells induced by this mixture of Clostridium clusters are negative
for Helios, which indicates the preferential induction of iTreg cells.
Clostridium clusters not only promote the generation of Foxp3+
Treg cells, but also enhance their suppressive capacity by increas-
ing the production of IL-10 and expression of cytotoxic T lympho-
cyte antigen 4 (CTLA-4) [11]. Reﬂecting the beneﬁcial role of
Clostridium clusters on Foxp3+ Treg cell induction and functions,
mice inoculated with Clostridium clusters show higher resistance
to experimental colitis [11]. As for the mechanism of Foxp3+ Treg
cell induction mediated by Clostridium clusters, several pathways
may be involved. In the mice colonized with Clostridium clusters,
enhanced production of the active form of TGF-b is observed in
the colonic epithelial cells. Moreover, the expression of matrix
metalloproteinases (MMPs), such as MMP2, MMP9 and MMP13,
which convert latent TGF-b to the active form, are also enhanced
in the epithelium of these mice. Additionally, the expression of
indoleamine 2,3-dioxygenase (IDO) is increased in the epithelium
of these mice [11]. However, it remains elusive which signaling
pathway plays the most important role in the induction of Foxp3+
Treg cells by Clostridium clusters. The signiﬁcant role of Clostridium
clusters on Foxp3+ Treg cell induction is further conﬁrmed in stud-
ies investigating the effect of human microbiota [30]. Inoculation
of chloroform-treated human feces from a healthy volunteer into
GF mice efﬁciently induced Foxp3+ Treg cells in the colon. After a
series of selection steps, a mixture of 17 strains of bacteria proved
to be a potent inducer of Foxp3+ Treg cells [30]. Genome sequenc-
ing further revealed that these 17 strains were comprised of mi-
crobes belonging to Clostridium clusters IV, XIVa and XVIII.
Accordingly, mice given this mixure of 17 strains showed higher
resistance to both TNBS-induced colitis and OVA-induced allergic
diarrhea [30]. It remains unclear whether this mixture of 17 strains
will be able to promote the generation of Foxp3+ Treg cells in the
human intestine.
In addition to Clostridia, the human commensal Bacteroides
fragilis is capable of enhancing the suppressive capacity of Foxp3+
Treg cells in the colon by enhancing IL-10 production [31]. As a
functional mechanism of inducing IL-10 production by Foxp3+ Treg
cells, a unique surface polysaccharide of B. fragilis, polysaccharide A
(PSA), is reported to play a critical role. In support of this, PSA de-
rived from B. fragilis binds to TLR2 on Foxp3+ Treg cells and pro-
motes the expression of IL-10 [31]. Reﬂecting the beneﬁcial effect
of B. fragilis on Foxp3+ Treg cells, mice given B. fragilis show higher
resistance against Helicobacter hepaticus infection and TNBS-in-
duced colitis [32]. In addition to suppressing pathological intesti-
nal inﬂammation, PSA from B. fragilis might have additional roles
in a steady state gut environment. It was recently shown that
PSA enables the colonization of B. fragilis in close proximity tocolonic crypts [31]. Thus, it is plausible that the regulatory function
of B. fragilis enables colonization by restricting local inﬂammatory
immune responses.5. Microbiota-derived bacterial fermentation products
inﬂuence regulatory T cells
The induction of Foxp3+ Treg cells in the intestine can be inﬂu-
enced by commensal microbes as described above. However, accu-
mulating evidence suggests that microbiota-derived bacterial
fermentation products are also potent inducers of Foxp3+ Treg cells
in the intestine [33–35]. For the digestion of certain dietary com-
ponents, such as ﬁber, both humans and mice rely on the presence
of intestinal microbiota. Short-chain fatty acids (SCFAs) are a major
fermentation product produced from ﬁber by intestinal microbiota.
In contrast to the substantial amount of SCFAs present in the intes-
tinal lumens of SPF mice, SCFAs, including acetic acid, propionic
acid and butyric acid, are remarkably reduced in GF mice [33].
When GF mice were given SCFAs in their drinking water, each of
the SCFAs mentioned is capable of increasing the number of Foxp3+
Treg cells exclusively in the colon [33]. In addition to enhanced
proliferative capacity, Foxp3+ Treg cells induced by SCFAs show
higher expression of IL-10. In agreement with this, Foxp3+ Treg
cells incubated with SCFAs show an increased suppressive capacity
against effector T cells in vitro [33]. The beneﬁcial effect conferred
by SCFAs can also be attributed to the imprinting of gut homing
tropism onto Foxp3+ Treg cells. It is reported that SCFAs directly
enhance the expression level of G protein coupled receptor 15
(GPR15) on Foxp3+ Treg cells, thereby facilitating migration of
Foxp3+ Treg cells to the colon [33].
Although little was known regarding the homing mechanism of
colonic Foxp3+ Treg cells, recently GPR15 was identiﬁed as one of
the critical molecules in this process [36]. Approximately 60–70%
of Foxp3+ Treg cells in the colon express GPR15, and mice deﬁcient
for GPR15 show reduced numbers of Foxp3+ Treg cells exclusively
in the colon. The critical role of GPR15 in protection against path-
ogenic intestinal inﬂammation, as modeled by Citrobacter roden-
tium infection, has also been investigated [36]. Interestingly, in
this report it was shown that GPR15 expression is decreased in
mice treated with broad-spectrum antibiotics [36]. The precise
mechanism for this remains elusive, but one of the possibilities is
that certain bacterial species sensitive to antibiotics are capable
of producing large amount of SCFAs.
As for the detection mechanism of SCFAs by Foxp3+ Treg cells,
GPR43 is considered to be the putative receptor of SCFAs. Support-
ing this hypothesis, Foxp3+ Treg cells of mice deﬁcient for Ffar2,
encoding GPR43, are refractory to propionate-treatment [33]. Fur-
thermore, the expression level of Ffar2 is more highly expressed in
Foxp3+ Treg cells of the colon than those derived from other or-
gans. In GF mice the speciﬁc expression pattern of GPR43 on
Foxp3+ Treg cells is abolished, indicating that GPR43 expression
is driven by commensal microbiota [33].
After the detection of SCFAs by GPR43, histone deacetylase
(HDAC) inhibition is suggested to be one of the downstreammech-
anisms that modify Foxp3+ Treg cell functions. Indeed, propionate-
treatment is demonstrated to reduce the expression of HDAC6 and
HDAC9 in Foxp3+ Treg cells, leading to enhanced histone acetyla-
tion in a Ffar2-dependent manner [33].
Of the three major SCFAs, butyrate and propionate, but not ace-
tate, inhibit HDAC. In agreement with this, recent reports showed
that propionic acid and butyric acid are capable of inducing Foxp3+
Treg cells [34]. Since the concentration of SCFAs and the experi-
mental protocols applied in each study was not consistent, it is still
open for discussion which type of SCFAs is the most potent in pro-
moting Foxp3+ Treg cells in vivo.
M. Kinoshita, K. Takeda / FEBS Letters 588 (2014) 4182–4187 4185Finally, regarding the type of Foxp3+ Treg cells, SCFAs are sug-
gested to have the more prominent effect on extrathymic genera-
tion of Foxp3+ Treg cells than thymus-derived Foxp3+ Treg cells.
This is supported by the effect mediated by SCFAs being dependent
on CNS1, which is an essential factor for the generation of iTreg
cells in the periphery as discussed above [34].
6. Dietary vitamins maintain regulatory T cells
In addition to gut microbiota and microbiota-derived metabo-
lites, certain types of dietary components have a direct effect on
immune cells. Recent studies revealed the essential role of vita-
mins on the maintenance of Foxp3+ Treg cells in the intestines.
Vitamins are organic compounds which the host is unable to syn-
thesize itself. Therefore, intake from the diet is considered to be
essential for the sufﬁcient supply of each vitamin. There are both
hydrophilic and hydrophobic vitamins, such as vitamins B and C,
and vitamins A, D, E and K, respectively. For the proper mainte-
nance of gut immunity, the essential role of vitamin A has been
well investigated [37,38], and recently vitamin B9, or folic acid, is
also revealed to be an essential factor for the survival of intestinal
Foxp3+ Treg cells [39,40].
Vitamin A is contained in the diet in the form of all-trans-reti-
nol, retinyl esters, or b-carotene. These products will be converted
into retinol in the tissues, and then to RA by RALDH, which is
highly expressed by CD103+ dendritic cells in the intestine. The
most critical role of RA in intestinal immunity is its capacity to im-
print gut-homing tropism on T cells [41]. T cells exposed to RA
have enhanced expression of both a4b7 integrin and CCR9, which
are critical receptors for migration to the small intestine [37,38].
Accordingly, in mice fed a vitamin A-deﬁcient diet, the number
of T cells is remarkably reduced in the small intestine [37,38]. Be-
sides gut-homing imprinting, RA produced by CD103+ dendritic
cells in combination with TGF-b preferentially promotes the differ-
entiation of Foxp3+ Treg cells from naïve CD4+ T cells. In addition to
the generation of Foxp3+ Treg cells, RA also inhibits the induction
of Th17 cells by antagonizing the effect of IL-6 and TGF-b [42].
Thus, vitamin A metabolites have a pivotal role in maintaining
the tropism and differentiation of Foxp3+ Treg cells in the intestine.
Therefore, the therapeutic effect of RA against intestinal inﬂamma-
tion is expected to be promising, as already suggested by several
reports utilizing murine intestinal inﬂammation models [43,44].
Vitamin D3, is either produced from 7-dehydrocholesterol at the
skin after the exposure to the sunlight, or absorbed from the diet.
Vitamin D3 can then be catabolized into several metabolites, such
as 25-dihydroxyvitamin D3 (25(OH)VD3) and the most active form
of 1,25(OH)2VD3 [45]. The critical role of vitamin D3 in regulating
intestinal inﬂammation is demonstrated in several models of IBD.
1,25(OH)2VD3 treatment is reported to inhibit colitis induced by
trinitrobenzene sulfonic acid by changing pro-inﬂammatory T cell
into regulatory T cell proﬁle [46]. In accordance with this, IL-10-
deﬁcient mice fed with vitamin D-deﬁcient diet develop a more ra-
pid and severe disease course [47]. Although it is reported that
1,25(OH)2VD3 treatment is capable of inducing IL-10 producing T
cells in vitro [48], whether vitamin D3 and its metabolites can af-
fect Foxp3+ Treg cells remains elusive. While pretreatment of den-
dritic cells with 1,25(OH)2VD3 leads to the induction of Foxp3+ Treg
cells in vitro [49], mice deﬁcient for vitamin D receptor does not
reportedly show any impairment in the number and the function
of Foxp3+ Treg cells in vivo [50].
On the other hand, vitamin B9, also known as folic acid, has long
been recognized as an essential nutrient for nucleic acid and
protein synthesis. Thus, vitamin B9 is involved in various cellular
processes including cell proliferation and survival. Previously it
was reported that vitamin B9 deﬁciency will lead to reducedactivity of NK cells [51]. Recently it was also revealed that a vita-
min B9 metabolite is able to directly bind MR1, a MHC class I-re-
lated molecule expressed on mucosa-associated invariant T cells
[52]. Previous studies showed that Foxp3+ Treg cells preferentially
express a subtype of the receptor which detects folic acid, folate
receptor 4 (FR4) [53]. The inﬂuence of vitamin B9 on Foxp3+ Treg
cells was proven in studies showing that mice fed a vitamin B9
deﬁcient diet show reduced number of Foxp3+ Treg cells in the
intestines [39,40]. Both in vitro and in vivo studies suggest that
vitamin B9 has a pivotal role in the maintenance of Foxp3+ Treg cell
survival [39,40]. Foxp3+ Treg cells cultured in vitamin B9-deﬁcient
conditions show a higher frequency of apoptosis, together with re-
duced expression of Bcl-2 [39,40]. It was further elucidated that
vitamin B9 enhanced survival independently of IL-2 signaling
[39]. It is of note that the effect of vitamin B9-deﬁciency is ob-
served exclusively in the intestine. This might reﬂect the high acti-
vation status of Foxp3+ Treg cells exposed to commensal
microbiota. It is remains controversial whether vitamin B9 has a
more signiﬁcant role on the maintenance of Foxp3+ Treg cells in
the small intestine or in the colon. In addition to dietary vitamin
B9, vitamin B9 can be generated by certain species of commensal
microbiota, such as those belonging to the Biﬁdobacterium genera
[54]. Thus the effect of vitamin B9 deﬁciency on Foxp3+ Treg cells
can be inﬂuenced by either the composition of intestinal microbi-
ota or the activation status of the Foxp3+ Treg cells of interest.
7. Energy source of regulatory T cells
It has been well recognized that in spite of the hypo-responsive-
ness of Foxp3+ Treg cells after TCR stimulation in vitro, they show
higher proliferative capacity compared with other T cell popula-
tions in vivo. In agreement with this, phenotypically Foxp3+ Treg
cells have a highly activated signature in vivo. The distinct meta-
bolic signatures of Foxp3+ Treg cells and effector T cells were re-
cently elucidated by several studies. In this regard, Foxp3+ Treg
cells possess a higher metabolic rate, and will be able to respond
more rapidly to environmental stimuli [55,56].
Foxp3+ Treg cells are unique in that they express various envi-
ronmental sensors, including CD25, FR4 and CD39 [56]. The critical
role of IL-2 for the survival of Foxp3+ Treg cells is well documented,
highlighting the signiﬁcance of CD25 expressed on Foxp3+ Treg
cells. The essential role of FR4 for the survival of intestinal Foxp3+
Treg cells is already discussed above [39,40]. The indispensable
role of CD39 expressed on Foxp3+ Treg cells is also reported in
the literature. CD39 is a membrane-bound ectonucleotidase that
converts extracellular ATP into adenosine. The generated adeno-
sine is capable of inhibiting the proliferation of effector T cells
[57,58]. Thus, it is postulated that Foxp3+ Treg cells respond rap-
idly to extracellular ATP, which is mostly regarded as tissue dam-
age signal, and exert suppressive effects on the surrounding
inﬂammatory T cell subsets. Thus, Foxp3+ Treg cells possess vari-
ous mechanisms to respond rapidly to the surrounding stimuli,
which include the cytokine milieu, tissue damage signals and
nutritional status. Moreover, it is noteworthy that the expression
pattern of these surface molecules, particularly CD25 and FR4, is
correlated with the activation status of T cells in general [53].
The stimulation of TCR with its speciﬁc antigen also moderately
enhances the expression of CD25 and FR4 on effector T cells [53].
As a sensing mechanism of the environmental and cellular
nutritional status, recent evidence demonstrates the critical role
of the mammalian target of rapamycin (mTOR) pathway in various
types of cells. mTOR is an evolutionarily conserved serine-threo-
nine kinase that serves as a highly sensitive sensor for nutrients,
including amino acids, glucose and growth factors. mTOR signaling
is mediated by two distinct complexes, mTORC1 and mTORC2, and
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Recently it was reported that TCR and IL-2 stimulation lead to
mTORC1 activation in Foxp3+ Treg cells [60]. The critical role of
the mTOR pathway in Foxp3+ Treg cells was further elucidated
by analyzing mice deﬁcient for Raptor, an essential component of
mTORC1. These mice show extensive lymphadenopathy and inﬁl-
tration of lymphocytes in various organs including the colonic mu-
cosa [60]. As a mechanism of enhancing the suppressive capacity of
Foxp3+ Treg cells, it was shown that the mTORC1/Raptor pathway
promotes proliferation and the induction of CTLA-4 and ICOS in
Foxp3+ Treg cells by enhancing lipid biosynthetic pathways, more
precisely the mevalonate pathway [60]. However, according to pre-
vious reports, the mTOR pathway can act either in a positive or
negative fashion on Foxp3+ Treg cells. Studies utilizing rapamycin,
the speciﬁc inhibitor of mTOR, show that the proliferation of
Foxp3+ Treg cells can be enhanced, at least in vitro. In addition,
for the differentiation of Foxp3+ Treg cells from naïve CD4+ T cells,
numerous reports show that the mTOR pathway negatively regu-
lates the conversion of naïve CD4+ T cells into Foxp3+ Treg cells.
It is postulated that mTORC1 activation can either directly affect
HIF1a or FOXO3a, or indirectly regulate SMAD3 after TGF-b stimu-
lation [61].
Nevertheless, taking into account that Foxp3+ Treg cells are a
highly activated T cell subset responding rapidly to environmental
and nutritional stimuli, it is attractive to hypothesize that for the
maintenance of these cells in the intestines, it is essential for Foxp3+
Treg cells to have access to sufﬁcient nutrients to fuel their high en-
ergy requirements through activation of the mTOR pathway.
8. Conclusion
Over the past few decades, our understanding has dramatically
increased regarding the critical role of Foxp3+ Treg cells in regulat-
ing intestinal inﬂammation. Therefore, it is an attractive hypothe-
sis that indigenous microbiota or dietary factors can induce or
enhance the suppressive capacity of Foxp3+ Treg cells. A better
understating of the mechanism of Foxp3+ Treg cell induction by
commensal bacteria, and identiﬁcation of the nutritional require-
ments of these cells, will greatly help us to develop novel therapeu-
tic treatments for patients with intestinal inﬂammation.
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